Cell senescence in neuropathology: A focus on neurodegeneration and tumours
Open accessThe DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Abstract
The study of cell senescence is a burgeoning field. Senescent cells can modify the cellular microenvironment through the secretion of a plethora of biologically active products referred to as the senescence‐associated secretory phenotype (SASP). The consequences of these paracrine signals can be either beneficial for tissue homeostasis, if senescent cells are properly cleared and SASP activation is transient, or result in organ dysfunction, when senescent cells accumulate within the tissues and SASP activation is persistent. Several studies have provided evidence for the role of senescence and SASP in promoting age‐related diseases or driving organismal ageing. The hype about senescence has been further amplified by the fact that a group of drugs, named senolytics, have been used to successfully ameliorate the burden of age‐related diseases and increase health and life span in mice. Ablation of senescent cells in the brain prevents disease progression and improves cognition in murine models of neurodegenerative conditions. The role of senescence in cancer has been more thoroughly investigated, and it is now accepted that senescence is a double‐edged sword that can paradoxically prevent or promote tumourigenesis in a context‐dependent manner. In addition, senescence induction followed by senolytic treatment is starting to emerge as a novel therapeutic avenue that could improve current anti‐cancer therapies and reduce tumour recurrence. In this review, we discuss recent findings supporting the role of cell senescence in the pathogenesis of neurodegenerative diseases and in brain tumours. A better understanding of senescence is likely to result in the development of novel and efficacious anti‐senescence therapies against these brain pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“An early landmark study revealed that the expression of oncogenic RAS, induces premature senescence in primary cell cultures, a process now known as oncogene-induced senescence (OIS) [38].”
BackgroundThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 1×
“These cells have diverse homeostatic roles in the CNS including neurotransmitter uptake/recycling, synaptic activity, maintenance of the blood brain barrier and inflammation [142].”
BackgroundClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“The first proof-of-concept that the ablation of senescent cells was beneficial and reduced ageingassociated disorders was published in 2011 [28, 77].”
BackgroundA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
The neuropathological diagnosis of Alzheimer's disease
DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329 · cited 1×
“The main pathological features that define AD are an accumulation of Aβ peptide amyloid plaques and neurofibrillary tangles (NFTs) of hyperphosphorylated tau proteins in the hippocampus and cerebral cortex [117].”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 2×
“Therefore, a consensus has been published, where a combination of markers is recommended to assess cellular senescence [5] Table 1.”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Research works printed but not linked: 80
- 10.1016/0014-4827(61)90192-6 · DOI · Paper page
- 10.1016/0014-4827(65)90211-9 · DOI · Paper page
- 10.1016/j.tcb.2018.02.001 · DOI · Paper page
- 10.3390/ijms20092158 · DOI · Paper page
- 10.1016/j.molmed.2020.03.005 · DOI · Paper page
- 10.15252/emmm.201810234 · DOI · Paper page
- 10.1007/s00109-018-1686-x · DOI
- 10.3233/JPD-191724 · DOI · Paper page
- 10.1073/pnas.92.20.9363 · DOI · Paper page
- 10.1038/s41556-018-0249-2 · DOI · Paper page
- 10.1038/onc.2017.235 · DOI
- 10.1016/j.celrep.2016.02.061 · DOI
- 10.1073/pnas.211053698 · DOI · Paper page
- 10.3389/fncel.2020.00016 · DOI · Paper page
- 10.1038/sj.onc.1203895 · DOI
- 10.1038/sj.cdd.4401962 · DOI · Paper page
- 10.1158/0008-5472.CAN-06-1569 · DOI
- 10.1084/jem.20161387 · DOI · Paper page
- 10.1016/j.cmet.2019.01.018 · DOI · Paper page
- 10.1002/(SICI)1097-4547(19990715)57:2<195::AID-JNR5>3.0.CO;2-P · doi:10.1002/(sici)1097-4547(19990715)57:2<195::aid-jnr5>3.0.co;2-p
- 10.1080/10715762.2018.1489128 · DOI
- 10.3390/nu12051344 · DOI
- 10.1002/1878-0261.12761 · DOI · Paper page
- 10.1126/science.aaf6659 · DOI · Paper page
- 10.1111/acel.13117 · DOI
- 10.1038/s41591-019-0549-5 · DOI · Paper page
- 10.1111/bpa.12216 · DOI · Paper page
- 10.3389/fnagi.2020.00148 · DOI · Paper page
- 10.1101/cshperspect.a006239 · DOI · Paper page
- 10.1111/acel.12641 · DOI · Paper page
- 10.1186/s13024-017-0207-7 · DOI · Paper page
- 10.1186/s13024-015-0035-6 · DOI · Paper page
- 10.1136/jnnp-2017-316201 · DOI · Paper page
- Cacabelos R, 1994, Brain interleukin‐1beta in Alzheimer’s disease and vascular dementia, Methods Find Exp Clin Pharmacol., 16, 141
- 10.1016/j.biopsych.2010.06.012 · DOI · Paper page
- 10.1111/j.1365-2990.2012.01306.x · DOI · Paper page
- 10.3233/JAD-2011-101014 · DOI · Paper page
- 10.1038/s41593-020-0624-8 · DOI · Paper page
- Wang WY, 2015, Role of pro‐inflammatory cytokines released from microglia in Alzheimer’s disease, Ann Transl Med., 3, 136
- 10.1093/hmg/ddr451 · DOI
- 10.7150/thno.19824 · DOI
- Ghasemi N, 2017, Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell‐based therapy, Cell J, 19, 1
- 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F · DOI · Paper page
- 10.1073/pnas.1818348116 · DOI · Paper page
- Müller HL, 2019, Craniopharyngioma, Nat Rev Dis Prim., 5, 1
- 10.1159/000506904 · DOI · Paper page
- 10.1007/s00401-018-1830-2 · DOI · Paper page
- 10.1080/23723556.2018.1435180 · DOI
- 10.1007/s00401-012-0957-9 · DOI · Paper page
- 10.1186/s40478-016-0321-8 · doi:10.1186/s40478-016-0321-8
- 10.1073/pnas.1101553108 · DOI · Paper page
- Andoniadou CL, 2013, The Sox2 + population of the adult murine pituitary includes progenitor/stem cells with tumour‐inducing potential, Cell Stem Cell, 419
- 10.1111/bpa.12501 · DOI
- 10.1186/s40478-020-00902-z · DOI · Paper page
- 10.1212/01.wnl.0000277271.47601.a1 · DOI
- 10.1146/annurev-genet-120417-031642 · DOI
- 10.1038/ng.2682 · DOI · Paper page
- 10.1158/1078-0432.CCR-11-0127 · DOI · Paper page
- 10.1158/1078-0432.CCR-10-0438 · DOI
- 10.1158/0008-5472.CAN-09-1851 · DOI · Paper page
- 10.1007/s00401-018-1837-8 · DOI · Paper page
- 10.1097/NEN.0000000000000188 · DOI · Paper page
- 10.1007/s00401-020-02127-9 · DOI · Paper page
- 10.3389/fonc.2019.00963 · DOI · Paper page
- 10.1158/0008-5472.CAN-18-1733 · DOI · Paper page
- 10.3389/fonc.2018.00503 · DOI
- 10.3390/ijms20071562 · DOI
- 10.18632/oncotarget.26502 · DOI
- 10.1016/j.ijrobp.2018.08.033 · DOI
- 10.3171/jns.2006.105.1.111 · DOI
- 10.1016/j.canlet.2020.06.023 · DOI
- 10.1073/pnas.1321014111 · DOI · Paper page
- Rahman M, 2020, Selective vulnerability of senescent glioblastoma cells to Bcl‐XL inhibition, bioRxiv
- Northcott PA, 2019, Medulloblastoma, Nat Rev Dis Prim., 5, 1
- 10.1158/0008-5472.CAN-17-4060 · DOI
- 10.1007/s00401-016-1545-1 · DOI · Paper page
- 10.1097/PAS.0b013e318294e817 · DOI
- Flannery PC, 2018, Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma, Oncol Rep., 39, 455
- 10.1016/j.celrep.2020.108286 · DOI
- 10.4061/2011/857484 · DOI · Paper page
Cited by
Neuroinflammation in Alzheimer’s Disease
Onyango, I. G., Jauregui, G. V., Čarná, M., Bennett, J. P., & Stokin, G. B. (2021) · Biomedicines · doi:10.3390/biomedicines9050524 · Cited by 330
Cellular senescence at the crossroads of inflammation and Alzheimer's disease
Guerrero, A., De Strooper, B., & Arancibia-Cárcamo, I. L. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.06.007 · Cited by 236
Alzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
Cellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
Metadata
- Authors
- Carreno, G., Guiho, R., & Martinez‐Barbera, J. P.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2021-02
- Volume
- 47
- Issue
- 3
- Pages
- 359-378
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W3116069652
- Cited by
- 74
- References
- 118
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Cancer Research UK
- Children's Cancer and Leukaemia Group
- CHILDREN with CANCER UK
- University College London
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cell senescence in neuropathology: A focus on neurodegeneration and tumours. https://app.cochat.ai/papers/10.1111/nan.12689
- The paper
- Carreno, G., Guiho, R., & Martinez‐Barbera, J. P. (2021). Cell senescence in neuropathology: A focus on neurodegeneration and tumours. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12689
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.